The Exclusivity of Our Innovation
Regenyal Biorivolumetria is an exclusive, patent-protected method. It combines advanced research, green technologies, and clinical safety. Our approach is unique within the landscape of individual health, as it creates products that act at depth while respecting physiology. Innovation becomes identity; the patent is the guarantee of a distinctive result.
A Monophasic Gel with Superior Integration
The Regenyal patent describes a monophasic gel characterised by high cohesivity, homogeneity, and ease of injection. The balance between viscosity and plasticity makes it ideal for tissue integration. The gel ensures excellent volumetric yield, natural results, and long-lasting efficacy. This exclusive solution is perfect for redefining volumes and stimulating regeneration with maximum safety. The patent protects an internally developed technology, the fruit of our continuous research oriented towards physiological beauty.
Discover the Biorivolumetria®
The Gentle Cross-linking process, homogeneity and clinical performance
The patent involves a delicate cross-linking process at low temperatures, which preserves the biological properties of the hyaluronic acid. The result is a uniform, easily injectable, stable, and highly biocompatible gel. Clinical performances are superior: risk reduction, excellent integration, a natural aesthetic effect, and prolonged duration over time.
Are you a professional looking for more information?
Would you like to integrate our devices into your practice? Write to us to receive technical data sheets, personalized consultations, and dedicated training support for healthcare professionals interested in our products.
Contact us here
